21779871|critical|C1547298^C1511545^C1547308^C1552746^C1579038^C1551396|start=0|end=8|CONC
21779871|role|C1705809^C0035820^C1705812^C1704326^C1705811^C1705810|start=9|end=13|ACTI^CONC
21779871|motif|C1514562|start=32|end=37|GENE
21779871|ccr2|C1413188|start=51|end=55|GENE
21779871|apoe|C1412481^C0523511|start=71|end=75|PROC^GENE
21779871|mouse model|C2986594|start=80|end=91|DISO
21779871|metabolic syndrome|C0524620|start=99|end=117|DISO
21779871|aims|C1947946^C3540473|start=119|end=123|CONC
21779871|hypothesis|C1512571|start=124|end=134|CONC
21779871|motif|C1514562|start=190|end=195|GENE
21779871|ccr2|C1413188|start=209|end=213|GENE
21779871|may|C3812381|start=215|end=218|CONC
21779871|contribute|C1880177|start=219|end=229|ACTI
21779871|pathogenesis|C0543483^C0699748|start=237|end=249|DISO^CONC
21779871|metabolic syndrome|C0524620|start=257|end=275|DISO
21779871|effects|C1280500|start=286|end=293|CONC
21779871|inflammatory|C0333348|start=297|end=309|CONC
21779871|monocytes|C0200637^C0026473|start=310|end=319|PROC^ANAT
21779871|increased|C0442805^C0205217|start=321|end=330|CONC
21779871|ccr2|C1413188|start=347|end=351|GENE
21779871|inflammatory|C0333348|start=359|end=371|CONC
21779871|monocytes|C0200637^C0026473|start=372|end=381|PROC^ANAT
21779871|epididymal|C0014533|start=385|end=395|ANAT
21779871|fat pads|C0935625|start=396|end=404|ANAT
21779871|thought|C0039869|start=408|end=415|PHYS
21779871|development|C1527148^C0243107^C3272564^C0678723|start=430|end=441|PHYS^CONC
21779871|insulin resistance|C2700570^C0021655|start=445|end=463|DISO^GENE
21779871|resulting|C0678226|start=481|end=490|CONC
21779871|hyperglycaemia|C0020456|start=491|end=505|DISO
21779871|dyslipidaemia|C0242339|start=510|end=523|DISO
21779871|contribute|C1880177|start=524|end=534|ACTI
21779871|development|C1527148^C0243107^C3272564^C0678723|start=538|end=549|PHYS^CONC
21779871|metabolic syndrome|C0524620|start=557|end=575|DISO
21779871|complications|C1171258^C0009566^C0802632|start=576|end=589|DISO^PHYS
21779871|cardiovascular disease|C0007222|start=598|end=620|DISO
21779871|diabetic nephropathy|C0011881^C1442864|start=625|end=645|DISO^GENE
21779871|goal|C0018017^C1571704|start=651|end=655|CONC
21779871|role|C1705809^C0035820^C1705812^C1704326^C1705811^C1705810|start=677|end=681|ACTI^CONC
21779871|ccr2|C1413188|start=685|end=689|GENE
21779871|inflammatory|C0333348|start=694|end=706|CONC
21779871|monocytes|C0200637^C0026473|start=707|end=716|PROC^ANAT
21779871|mouse model|C2986594|start=722|end=733|DISO
21779871|metabolic syndrome|C0524620|start=759|end=777|DISO
21779871|methods|C0025664^C0449851^C0025663|start=779|end=786|CONC
21779871|generated|C3146294|start=791|end=800|ACTI
21779871|model|C0026336^C3714583^C3274659^C0026339^C3161035|start=803|end=808|DEVI^CONC
21779871|metabolic syndrome|C0524620|start=816|end=834|DISO
21779871|backcrossing|C0524616|start=838|end=850|PHYS
21779871|apoe|C1412481^C0523511|start=867|end=871|PROC^GENE
21779871|mice|C1413131^C1417166|start=880|end=884|GENE
21779871|apoe|C1412481^C0523511|start=897|end=901|PROC^GENE
21779871|role|C1705809^C0035820^C1705812^C1704326^C1705811^C1705810|start=927|end=931|ACTI^CONC
21779871|ccr2|C1413188|start=935|end=939|GENE
21779871|model system|C0026339^C3161035|start=948|end=960|DEVI^CONC
21779871|apoe|C1412481^C0523511|start=982|end=986|PROC^GENE
21779871|mice|C1413131^C1417166|start=995|end=999|GENE
21779871|presence of|C0150312|start=1026|end=1037|CONC
21779871|obesity|C0028754|start=1038|end=1045|DISO
21779871|insulin resistance|C2700570^C0021655|start=1047|end=1065|DISO^GENE
21779871|dyslipidaemia|C0242339|start=1067|end=1080|DISO
21779871|increased|C0442805^C0205217|start=1085|end=1094|CONC
21779871|systemic|C0205373|start=1095|end=1103|CONC
21779871|inflammation|C0021368|start=1104|end=1116|DISO
21779871|model|C0026336^C3714583^C3274659^C0026339^C3161035|start=1123|end=1128|DEVI^CONC
21779871|manifested|C1280444^C0205319|start=1134|end=1144|CONC
21779871|complications|C1171258^C0009566^C0802632|start=1149|end=1162|DISO^PHYS
21779871|metabolic syndrome|C0524620|start=1170|end=1188|DISO
21779871|atherosclerosis|C0003850^C0004153|start=1190|end=1205|DISO
21779871|diabetic nephropathy|C0011881^C1442864|start=1210|end=1230|DISO^GENE
21779871|inactivation|C0544461|start=1232|end=1244|CONC
21779871|ccr2|C1413188|start=1248|end=1252|GENE
21779871|apoe|C1412481^C0523511|start=1265|end=1269|PROC^GENE
21779871|mice|C1413131^C1417166|start=1278|end=1282|GENE
21779871|metabolic syndrome|C0524620|start=1305|end=1323|DISO
21779871|atherosclerosis|C0003850^C0004153|start=1336|end=1351|DISO
21779871|diabetic nephropathy|C0011881^C1442864|start=1356|end=1376|DISO^GENE
21779871|phenotype|C0031437^C1285572|start=1394|end=1403|PROC^PHYS
21779871|associated with|C0332281|start=1408|end=1423|CONC
21779871|reduced|C0392756|start=1426|end=1433|CONC
21779871|number|C1554106^C0449788^C0237753|start=1434|end=1440|CONC
21779871|inflammatory|C0333348|start=1444|end=1456|CONC
21779871|monocytes|C0200637^C0026473|start=1457|end=1466|PROC^ANAT
21779871|liver|C2346688^C1278929^C0023884^C0736268|start=1474|end=1479|OBJC^ANAT
21779871|muscle|C0026845|start=1484|end=1490|ANAT
21779871|epididymal|C0014533|start=1507|end=1517|ANAT
21779871|fat pads|C0935625|start=1518|end=1526|ANAT
21779871|circulating|C0175630|start=1528|end=1539|CONC
21779871|levels|C0441889|start=1540|end=1546|CONC
21779871|leptin|C1416825^C1295176|start=1569|end=1575|PROC^GENE
21779871|resistin|C1426906^C2699063|start=1577|end=1585|PROC^GENE
21779871|adiponectin|C2700366^C2986675^C1540187|start=1590|end=1601|PROC^GENE
21779871|reduced|C0392756|start=1616|end=1623|CONC
21779871|proportion|C1709707|start=1644|end=1654|CONC
21779871|inflammatory|C0333348|start=1658|end=1670|CONC
21779871|monocytes|C0200637^C0026473|start=1671|end=1680|PROC^ANAT
21779871|liver|C2346688^C1278929^C0023884^C0736268|start=1688|end=1693|OBJC^ANAT
21779871|pancreas|C1278931^C0030274|start=1695|end=1703|ANAT
21779871|muscle|C0026845|start=1708|end=1714|ANAT
21779871|epididymal|C0014533|start=1731|end=1741|ANAT
21779871|fat pads|C0935625|start=1742|end=1750|ANAT
21779871|correlated|C1707520|start=1752|end=1762|CONC
21779871|peripheral|C0205100|start=1782|end=1792|CONC
21779871|glucose levels|C0428548|start=1793|end=1807|PHEN
21779871|conclusions|C1707478|start=1809|end=1820|CONC
21779871|interpretation|C0459471^C3173575|start=1821|end=1835|PHYS^CONC
21779871|ccr2|C1413188|start=1837|end=1841|GENE
21779871|inflammatory|C0333348|start=1849|end=1861|CONC
21779871|monocyte|C0026473|start=1862|end=1870|ANAT
21779871|liver|C2346688^C1278929^C0023884^C0736268|start=1891|end=1896|OBJC^ANAT
21779871|muscle|C0026845|start=1901|end=1907|ANAT
21779871|may be a|C1278418|start=1908|end=1916|CONC
21779871|critical|C1547298^C1511545^C1547308^C1552746^C1579038^C1551396|start=1917|end=1925|CONC
21779871|factor|C1521761^C2827422|start=1937|end=1943|CONC
21779871|development|C1527148^C0243107^C3272564^C0678723|start=1951|end=1962|PHYS^CONC
21779871|metabolic syndrome|C0524620|start=1970|end=1988|DISO
